Minerva Neurosciences, Inc - Common Stock — Quarterly Financial Statistics (NASDAQ:NERV) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -4.07 M-2.04 M-2.92 M-4.48 M-5.43 M-13.34 M -26.17 M Cash from investing activities 0000-45.29 M-4.83 M -50.13 M Cash from financing activities 00-45.17 K74.5 M1.08 M10.17 M 85.7 M Free cash flow -4.07 M-2.04 M-2.92 M-4.48 M-5.43 M-13.34 M -26.17 M

News

All You Need to Know About Minerva Neurosciences (NERV) Rating Upgrade to Buy

Minerva Neurosciences (NERV) Loses 37.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

H.C. Wainwright raises Minerva Neurosciences price target on trial design

Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript

Minerva Neurosciences appoints schizophrenia expert to board of directors

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.47%

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial - Minerva Neurosciences (NASDAQ:NERV)

Minerva Neurosciences stock soars after securing $200 million financing

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - American Rebel Holdings (NASDAQ:AREB), Beyond Meat (NASDAQ:BYND)